tirzepatide single dose vials lilly vial releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Eli Lilly's Zepbound available in – Eli Lilly to release single-dose

Common Questions from Fellow GLP-1 Warriors Wondering how much weight you might lose

Constipation, bloating, and occasional vomiting happen too

Reaching for anything above my head

Medicare Part D coverage expansion: The proposed CMS rule allowing Medicare Part D plans to cover anti-obesity medications would make 31 million Medicare beneficiaries with obesity eligible for semaglutide and tirzepatide, representing a USD 55.8 billion annual drug spend potential at 15% initial penetration

And work in lab animals has sparked concerns about developing thyroid cancer, though more recent research suggests that this isnt likely in people